Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2021 to Q2 2025

Type / Class
Equity / COMMON STOCK
Symbol
OMGAQ
Shares outstanding
55,351,475
Price per share
$0.02
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Flagship Ventures Fund V, L.P. 53% $1,461,279 29,225,579 Noubar Afeyan 29 Dec 2024
Flagship V VentureLabs Rx Fund, L.P. 53% 0% $1,461,279 -$336,554 29,225,579 0% Noubar Afeyan 03 Feb 2025

Institutional Holders of Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q2 0 $0 -$2,426 $0.02 0
2025 Q1 19,648 $2,426 -$35,238,961 $0.08 3
2024 Q4 47,281,697 $35,253,886 -$921,856 $0.75 50
2024 Q3 48,290,202 $58,913,912 -$6,029,323 $1.22 51
2024 Q2 50,536,326 $104,609,269 -$2,392,066 $2.07 66
2024 Q1 51,125,783 $186,608,609 +$3,748,687 $3.65 67
2023 Q4 50,206,798 $151,122,782 +$1,376,674 $3.01 62
2023 Q3 50,887,878 $109,409,866 -$615,060 $2.15 56
2023 Q2 51,093,635 $286,122,600 +$4,687,211 $5.60 58
2023 Q1 50,231,941 $302,897,871 +$25,616,806 $6.03 54
2022 Q4 16,768,091 $95,744,501 +$387,343 $5.71 46
2022 Q3 42,604,506 $230,915,000 +$907,410 $5.42 40
2022 Q2 42,484,051 $161,436,866 -$5,642,349 $3.80 44
2022 Q1 43,545,600 $271,743,574 +$3,782,679 $6.24 50
2021 Q4 42,043,809 $475,104,000 +$9,664,162 $11.33 43
2021 Q3 14,966,151 $277,952,000 +$277,952,000 $18.85 40